Single Dose Of Vaccine Candidate For Chikungunya Virus Appears Safe And Effective, Data Suggest
June 14, 2023
MedPage Today (6/13, Hein) reports, “A single dose of the live-attenuated vaccine candidate VLA1553 for the prevention of disease caused by chikungunya virus produced a strong immune response, a phase III randomized trial showed.” Data show that “at 28 da...